These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 24667820)
1. Characterization of bonds formed between platelet factor 4 and negatively charged drugs using single molecule force spectroscopy. Block S; Greinacher A; Helm CA; Delcea M Soft Matter; 2014 Apr; 10(16):2775-84. PubMed ID: 24667820 [TBL] [Abstract][Full Text] [Related]
2. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726 [TBL] [Abstract][Full Text] [Related]
3. Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds. Nguyen TH; Greinacher A; Delcea M Nanoscale; 2015 Jun; 7(22):10130-9. PubMed ID: 25981976 [TBL] [Abstract][Full Text] [Related]
4. Interactions of platelet factor 4 with the vessel wall. Sachais BS; Higazi AA; Cines DB; Poncz M; Kowalska MA Semin Thromb Hemost; 2004 Jun; 30(3):351-8. PubMed ID: 15282658 [TBL] [Abstract][Full Text] [Related]
5. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. Kreimann M; Brandt S; Krauel K; Block S; Helm CA; Weitschies W; Greinacher A; Delcea M Blood; 2014 Oct; 124(15):2442-9. PubMed ID: 25150299 [TBL] [Abstract][Full Text] [Related]
6. Biophysical tools to assess the interaction of PF4 with polyanions. Delcea M; Greinacher A Thromb Haemost; 2016 Oct; 116(5):783-791. PubMed ID: 27658429 [TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide. Fiore MM; Kakkar VV Biochem Biophys Res Commun; 2003 Nov; 311(1):71-6. PubMed ID: 14575696 [TBL] [Abstract][Full Text] [Related]
8. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation. Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy. Santos HA; Manzanares JA; Murtomäki L; Kontturi K Eur J Pharm Sci; 2007 Oct; 32(2):105-14. PubMed ID: 17643273 [TBL] [Abstract][Full Text] [Related]
11. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens. Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391 [TBL] [Abstract][Full Text] [Related]
12. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407 [TBL] [Abstract][Full Text] [Related]
13. Detection of epitopes in glycosaminoglycans immobilized on hydrophobic membranes. Björnsson S Scand J Clin Lab Invest Suppl; 2000; 233():27-35. PubMed ID: 11317939 [TBL] [Abstract][Full Text] [Related]
14. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography. Medici I; Di Martino A; Cella G; Callegaro L; Prosdocimi M Thromb Res; 1989 May; 54(4):277-87. PubMed ID: 2763268 [TBL] [Abstract][Full Text] [Related]
15. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. Kantarcioglu B; Darki A; Siddiqui F; Hoppensteadt D; Lewis J; Krämer R; Adiguzel C; Fareed J Clin Appl Thromb Hemost; 2022; 28():10760296221091770. PubMed ID: 35360982 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492 [TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226 [TBL] [Abstract][Full Text] [Related]
18. Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C. Dudek AZ; Pennell CA; Decker TD; Young TA; Key NS; Slungaard A J Biol Chem; 1997 Dec; 272(50):31785-92. PubMed ID: 9395524 [TBL] [Abstract][Full Text] [Related]
19. Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Aidoudi S; Bikfalvi A Thromb Haemost; 2010 Nov; 104(5):941-8. PubMed ID: 20806113 [TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia: frequency and pathogenesis. Greinacher A Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]